Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (621-630 of 716) with videos related to

Pageof 72
Sort By:
European Heart Journal. Cardiovascular Imaging|August 1, 2012
Global longitudinal strain predicts left ventricular dysfunction after mitral valve repairTomasz G Witkowski, James D Thomas, Philippe J M R Debonnaire, et al.
Journal of the American Heart Association|June 3, 2022
Validation of the WATCH-DM and TRS-HF<sub>DM</sub> Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort AnalysisMatthew W Segar, Kershaw V Patel, Anne S Hellkamp, et al.
The Lancet. Digital Health|November 25, 2022
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort studyJohn M Dennis, Katherine G Young, Andrew P McGovern, et al.
Biochemistry|May 27, 2016
Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-LipoxygenaseJoshua D Deschamps, Abiola F Ogunsola, J Brian Jameson, et al.
Journal of Natural Products|February 13, 2007
Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assayNadine C Gassner, Craig M Tamble, Jonathan E Bock, et al.
Infection|March 29, 2017
Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort studyS Janssen, K Osbak, R Holman, et al.
Diabetes, Obesity & Metabolism|March 25, 2018
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)Shelby D Reed, Yanhong Li, Jose Leal, et al.
Circulation|December 22, 2010
Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapyVictoria Delgado, Rutger J van Bommel, Matteo Bertini, et al.
The Annals of Thoracic Surgery|November 25, 2010
Clinical and functional effects of restrictive mitral annuloplasty at midterm follow-up in heart failure patientsEllen A ten Brinke, Robert J Klautz, Sven A Tulner, et al.
The Journal of Biological Chemistry|October 4, 2017
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumorsVictoria Stepanova, Konstantin V Dergilev, Kelci R Holman, et al.
Pageof 72

Showing results (621-630 of 716) with videos related to

Sort By:
Pageof 72
European Heart Journal. Cardiovascular Imaging|August 1, 2012
Global longitudinal strain predicts left ventricular dysfunction after mitral valve repairTomasz G Witkowski, James D Thomas, Philippe J M R Debonnaire, et al.
Journal of the American Heart Association|June 3, 2022
Validation of the WATCH-DM and TRS-HF<sub>DM</sub> Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort AnalysisMatthew W Segar, Kershaw V Patel, Anne S Hellkamp, et al.
The Lancet. Digital Health|November 25, 2022
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort studyJohn M Dennis, Katherine G Young, Andrew P McGovern, et al.
Biochemistry|May 27, 2016
Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-LipoxygenaseJoshua D Deschamps, Abiola F Ogunsola, J Brian Jameson, et al.
Journal of Natural Products|February 13, 2007
Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assayNadine C Gassner, Craig M Tamble, Jonathan E Bock, et al.
Infection|March 29, 2017
Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort studyS Janssen, K Osbak, R Holman, et al.
Diabetes, Obesity & Metabolism|March 25, 2018
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)Shelby D Reed, Yanhong Li, Jose Leal, et al.
Circulation|December 22, 2010
Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapyVictoria Delgado, Rutger J van Bommel, Matteo Bertini, et al.
The Annals of Thoracic Surgery|November 25, 2010
Clinical and functional effects of restrictive mitral annuloplasty at midterm follow-up in heart failure patientsEllen A ten Brinke, Robert J Klautz, Sven A Tulner, et al.
The Journal of Biological Chemistry|October 4, 2017
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumorsVictoria Stepanova, Konstantin V Dergilev, Kelci R Holman, et al.
Pageof 72